中文 | English
Return
Total: 5495 , 1/550
Show Home Prev Next End page: GO
Author:(Jing ZHOU)

1.Advances on correlation between Girdin protein and breast cancer

Jing ZHOU

Practical Oncology Journal 2016;30(1):57-60

2.The observation on the immunity state of lung cancer by radiotherapy in sync with chemotherapy combined with pingxiao capsule

Jing ZHOU

Journal of Chongqing Medical University 2007;0(09):-

3.Progress in biological mechanism of electric fields for tumor treating

Jing ZHOU

Journal of International Oncology 2009;36(11):840-842

4.Correlation between the Rorschach inkblot method and 16 personality factor questionnaire

Jing ZHOU ; Qingke GUO

Chinese Journal of Tissue Engineering Research 2006;10(42):191-193

5.Effect of comprehensive intervention on controlling surgical site infection in patients undergoing total abdominal hysterectomy

Jing ZHOU ; Li TAO

Chinese Journal of Infection Control 2016;(1):38-40

6.Allogeneicversus heterogeneous bone marrow mesenchymal stem cells for laryngeal cartilage repair

Yichang LIU ; Jing ZHOU

Chinese Journal of Tissue Engineering Research 2016;20(7):966-971

7.Curative Effect of Chuankezhi Injection Combined with Budesonide and Formoterol Fumarate Powder for Inhalation in the Treatment of Chronic Obstructive Pulmonary Disease

Jing JIANG ; Xiumei ZHOU

China Pharmacist 2015;(11):1938-1939,1940

8.Impact of hyperglycemia on prognosis for patients admitted to medical intensive care units

Bo ZHOU ; Jing LI

Chinese Journal of General Practitioners 2009;8(5):312-315

9.Investigation and analysis of the comprehensive quality status of community nurses in Chongqing

Jing DENG ; Yingqing ZHOU

Chinese Journal of Practical Nursing 2008;24(13):60-62

10.Treatment of detrusor-external sphincter dyssynergia caused by spinal cord injury with transperineal injection of botulin A toxin

Jing SHI ; Guochang ZHOU

Chinese Journal of Urology 2001;0(11):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5495 , 1/550 Show Home Prev Next End page: GO